Cannabis: Exploring the evidence and clinical implications with Dr. Kevin Hill

Cannabis: Exploring the evidence and clinical implications with Dr. Kevin Hill

Cannabis is often a hot topic, but how much do we really know about its clinical applications? In this episode of 'Quick Takes', Dr. David Gratzer sits down with Dr. Kevin Hill from Beth Israel Deaconess Medical Center and Harvard Medical School to discuss the latest evidence and implications of cannabis use in treatment. Dr. Hill, an addiction psychiatrist, dives into the complexities of using cannabinoids therapeutically, touching on everything from potential benefits to the pitfalls of current practices.

Ever wondered if cannabis could be effective for treating schizophrenia? Dr. Hill shares that while there are some promising data points, the science hasn’t quite caught up with the enthusiasm many patients have for using cannabis medicinally. He also talks about the link between long-term cannabis use and disorders like Alcohol Use Disorder (AUD) and Opioid Use Disorder (OUD), and why the doses of CBD and THC needed for therapeutic effects are often much higher than what people typically consume.

This episode doesn’t shy away from the controversial aspects of cannabis research. Dr. Hill highlights the challenges clinicians face, especially during the COVID-19 pandemic, and underscores the importance of supervised use of CBD. With cannabis being both understudied and under-regulated, his insights provide a crucial resource for anyone in the medical field.

Whether you’re a clinician looking to better understand cannabis use or a patient curious about its potential benefits and risks, this episode offers valuable perspectives on a complex and often misunderstood topic.